Intellectual Property Rights: Issues & Challenges in Covid Times - By Chandrakant Singh

Today in global pandemic, poor nations are struggling to develop vaccines and medicines for treatment of this fatal disease. Keeping this in mind WTO should simplify procedural wrangles on all fronts whether with respect to vaccines or medicines and on all essential IPRs associated in making vaccine.

Recently, the European Union has proposed that Intellectual Property Rights held by international pharmaceutical companies on COVID-19 vaccines may be relaxed for up to five years. This proposal comes in the backdrop of a festering two-year-old dispute at the World Trade Organisation involving India, the U.S., South Africa and the EU.

However, the reprieve will ....

Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Issue Analysis